During the past decade, Hospital Raja Perempuan Zainab II conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 12 clinical trials were completed, i.e. on average, 41.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 9 clinical trials were completed. i.e. 64.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Raja Perempuan Zainab II" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Bayer" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Hospital Sultanah Bahiyah" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Raja Perempuan Zainab II" #1 collaborator was "Hospital Enche Besar Hajjah Khalsom, Kluang, Johor" with 2 trials as a collaborator, "Hospital Melaka, Melaka" with 2 trials as a collaborator, "Hospital Queen Elizabeth, Malaysia" with 2 trials as a collaborator, "Hospital Raja Perempuan Zainab II, Kota Bahru, Kelantan" with 2 trials as a collaborator and "Hospital Raja Permaisuri Bainun" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Raja Perempuan Zainab II" are "COVID-19" (3 trials), "Ulcerative Colitis" (3 trials), "Anosmia" (2 trials), "Chronic Kidney Diseases" (2 trials) and "Dysgeusia" (2 trials). Many other conditions were trialed in "Hospital Raja Perempuan Zainab II" in a lesser frequency.

Most popular intervention types in "Hospital Raja Perempuan Zainab II" are "Drug" (26 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Etrolizumab" (2 trials), "Guselkumab" (2 trials), "Lansoprazole" (2 trials) and "Lansoprazole Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Raja Perempuan Zainab II" are 31 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Raja Perempuan Zainab II". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Hospital Raja Perempuan Zainab II, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Raja Perempuan Zainab II, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".